Cargando…
Syngeneic N1-S1 Orthotopic Hepatocellular Carcinoma in Sprague Dawley Rat for the Development of Interventional Oncology-Based Immunotherapy: Survival Assay and Tumor Immune Microenvironment
SIMPLE SUMMARY: Interventional oncology (IO) approaches have been highly effective in treating hepatocellular carcinoma (HCC) locoregionally. Recently revealed anti-cancer immunity of IO-based immunotherapies proposed the promise of enhanced immunotherapy. However, the development of those therapies...
Autores principales: | Choi, Bongseo, Pe, Jason, Yu, Bo, Kim, Dong-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913283/ https://www.ncbi.nlm.nih.gov/pubmed/36765871 http://dx.doi.org/10.3390/cancers15030913 |
Ejemplares similares
-
Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat.
por: Norback, D H, et al.
Publicado: (1985) -
Ovarian neoplasia in the Sprague-Dawley rat.
por: Lewis, D J
Publicado: (1987) -
Hematoxicity of Amodiaquine in Sprague-Dawley Rats
por: Saka, W. A., et al.
Publicado: (2012) -
Keishibukuryogan is not carcinogenic in Sprague-Dawley rats
por: Kanitani, Masanao, et al.
Publicado: (2016) -
Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats.
por: Owen, P E, et al.
Publicado: (1990)